Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative montelukast to reduce pain, nausea and vomiting after mandibular fracture surgery
IRCT20240517061819N4Phase 3Recruiting
- Sponsor
- Kerman University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast in Mandible fracture, postoperative pain and postoperative nausea and vomiting (PONV), sponsored by Kerman University of Medical Sciences. Primary endpoints: Postoperative pain intensity, Postoperative nausea and 1 more. Started Nov 2025; status: recruiting.
02
Drugs
montelukast
03
Conditions
Mandible fracturepostoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20240517061819N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240517061819N4.